Literature DB >> 32557915

Recognizing and controlling airborne transmission of SARS-CoV-2 in indoor environments.

Joseph G Allen1, Linsey C Marr2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32557915      PMCID: PMC7323102          DOI: 10.1111/ina.12697

Source DB:  PubMed          Journal:  Indoor Air        ISSN: 0905-6947            Impact factor:   5.770


× No keyword cloud information.
Sharing indoor space has been confirmed as a major risk factor in transmission of SARS‐CoV‐2. A study of over 7000 cases found that all outbreaks involving three or more people occurred indoors. Thus, identifying the dominant modes of transmission is an urgent public health priority so that appropriate control strategies can be selected and deployed. Here, we present three lines of evidence supporting the potential for airborne transmission and recommend steps to mitigate the risk in indoor environments.

DETECTION AND SURVIVAL OF CORONAVIRUS IN AIR

SARS‐COV‐2 viral RNA in air has been detected in several studies in hospitals, including at distances greater than 2 m from patients and in outdoor air in crowded areas near a hospital and a department store., , One study found that the majority of these viruses was associated with microscopic droplets (ie, aerosols) of diameter 2.5 microns and smaller, which can remain suspended in air for 2 hours or more. Another detected SARS‐COV‐2 in aerosols in the size range of 1‐4 microns. Furthermore, viral RNA has been detected on the surfaces of an air exhaust outlet and fan, places where direct transfer from an infected person could not occur. While these studies assayed viral RNA, the finding that SARS‐COV‐2 in fine aerosols (<5 microns) has a half‐life of 1 hour in terms of infectivity raises the possibility that some airborne virus is infectious. Concluding that transmission of SARS‐COV‐2 can occur via large droplet spray requires an assumption that the virus survives in such droplets. It is also reasonable, then, to assume the same for virus survival in aerosols. This is supported by empirical evidence. Previous studies have shown that other viruses survive equally well, if not better, in suspended aerosols compared to large droplets on surfaces., ,

ASYMPTOMATIC INFECTIVITY

There are reports of asymptomatic transmission of SARS‐CoV‐2. By definition, asymptomatic patients are not coughing or sneezing, which means they are not frequently generating large droplets. Therefore, for these asymptomatic patients, other modes of transmission, namely fomite and airborne, must be occurring. A study on patients with confirmed influenza infection has shown that infectious virus in aerosols smaller than 5 microns can be released by regular breathing and talking, without coughing. This is of concern because high shedding of infectious SARS‐CoV‐2 in the throat has been reported in individuals with no or mild symptoms .

AEROSOL PHYSICS

While the traditional distinction between “droplet” and “airborne” transmission of infectious disease has been useful for setting guidelines on the use of personal protective equipment, it has also established a false dichotomy in understanding the behavior of viruses in the air. Virus‐containing droplets that are released by breathing, talking, and coughing span a continuum of sizes, from 0.01 to hundreds of microns. It is impossible for someone to release “large droplets” (>5 microns) without also releasing smaller ones. Thus, transmission that is purported to occur via the spray of large droplets could in fact be occurring through inhalation of much smaller droplets at close range. In fact, a physics‐based simulation suggests that the majority of exposure at close range occurs by inhalation of small droplets rather than by contact with large droplets that land on the mouth, nose, and eyes, unless the people are closer than 30 cm or the droplets are very large.

RECOMMENDATIONS

Evidence is emerging indicating that, in addition to transmission via large droplets and fomites, SARS‐CoV‐2 is also transmitted via inhalation of aerosols. Recognition of this transmission route is critically important because there are measures we can take to reduce the risk of airborne transmission. These include increasing outdoor air ventilation rates above current minimums using high‐efficiency filtration for recirculated air (MERV 13 or greater) verifying that sensitive areas, such as bathrooms and rooms where infected patients are cared for in hospitals and senior homes, are negatively pressurized relative to adjacent areas managing air flow direction and speed to prevent spread of aerosols across occupants consideration of additional technological controls, such as UV germicidal irradiation and portable air purification, in areas and situations where typical building‐level controls are not sufficient using N95 respirators in healthcare settings. Last, these ventilation‐focused engineering controls must be supported by strategies that address fomite transmission because viruses in droplets and aerosols that have settled on the floor and other surfaces can be resuspended in air, where they can lead to inhalation exposure to the virus. Cleaning surfaces using vacuums with HEPA filtration and frequently cleaning and disinfecting surfaces are strategies that may also help reduce secondary airborne transmission.

AUTHOR CONTRIBUTION

Joseph Allen: Conceptualization (lead); Investigation (equal); Writing‐original draft (equal); Writing‐review & editing (equal). Linsey Marr: Conceptualization (supporting); Investigation (equal); Writing‐original draft (equal); Writing‐review & editing (equal).
  8 in total

1.  Aerodynamic analysis of SARS-CoV-2 in two Wuhan hospitals.

Authors:  Yuan Liu; Zhi Ning; Yu Chen; Ming Guo; Yingle Liu; Nirmal Kumar Gali; Li Sun; Yusen Duan; Jing Cai; Dane Westerdahl; Xinjin Liu; Ke Xu; Kin-Fai Ho; Haidong Kan; Qingyan Fu; Ke Lan
Journal:  Nature       Date:  2020-04-27       Impact factor: 49.962

2.  Humidity-Dependent Decay of Viruses, but Not Bacteria, in Aerosols and Droplets Follows Disinfection Kinetics.

Authors:  Kaisen Lin; Linsey C Marr
Journal:  Environ Sci Technol       Date:  2020-01-10       Impact factor: 9.028

3.  Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient.

Authors:  Sean Wei Xiang Ong; Yian Kim Tan; Po Ying Chia; Tau Hong Lee; Oon Tek Ng; Michelle Su Yen Wong; Kalisvar Marimuthu
Journal:  JAMA       Date:  2020-04-28       Impact factor: 56.272

4.  Influenza Virus Infectivity Is Retained in Aerosols and Droplets Independent of Relative Humidity.

Authors:  Karen A Kormuth; Kaisen Lin; Aaron J Prussin; Eric P Vejerano; Andrea J Tiwari; Steve S Cox; Michael M Myerburg; Seema S Lakdawala; Linsey C Marr
Journal:  J Infect Dis       Date:  2018-07-24       Impact factor: 5.226

5.  Environmental Persistence of Influenza Viruses Is Dependent upon Virus Type and Host Origin.

Authors:  Karen A Kormuth; Kaisen Lin; Zhihong Qian; Michael M Myerburg; Linsey C Marr; Seema S Lakdawala
Journal:  mSphere       Date:  2019-08-21       Impact factor: 4.389

6.  Infectious virus in exhaled breath of symptomatic seasonal influenza cases from a college community.

Authors:  Jing Yan; Michael Grantham; Jovan Pantelic; P Jacob Bueno de Mesquita; Barbara Albert; Fengjie Liu; Sheryl Ehrman; Donald K Milton
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-18       Impact factor: 11.205

7.  Asymptomatic and Human-to-Human Transmission of SARS-CoV-2 in a 2-Family Cluster, Xuzhou, China.

Authors:  Chunyang Li; Fang Ji; Liang Wang; Liping Wang; Jungui Hao; Mingjia Dai; Yan Liu; Xiucheng Pan; Juanjuan Fu; Li Li; Guangde Yang; Jianye Yang; Xuebing Yan; Bing Gu
Journal:  Emerg Infect Dis       Date:  2020-06-21       Impact factor: 6.883

8.  Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

Authors:  Neeltje van Doremalen; Trenton Bushmaker; Dylan H Morris; Myndi G Holbrook; Amandine Gamble; Brandi N Williamson; Azaibi Tamin; Jennifer L Harcourt; Natalie J Thornburg; Susan I Gerber; James O Lloyd-Smith; Emmie de Wit; Vincent J Munster
Journal:  N Engl J Med       Date:  2020-03-17       Impact factor: 91.245

  8 in total
  31 in total

Review 1.  The Lancet Commission on lessons for the future from the COVID-19 pandemic.

Authors:  Jeffrey D Sachs; Salim S Abdool Karim; Lara Aknin; Joseph Allen; Kirsten Brosbøl; Francesca Colombo; Gabriela Cuevas Barron; María Fernanda Espinosa; Vitor Gaspar; Alejandro Gaviria; Andy Haines; Peter J Hotez; Phoebe Koundouri; Felipe Larraín Bascuñán; Jong-Koo Lee; Muhammad Ali Pate; Gabriela Ramos; K Srinath Reddy; Ismail Serageldin; John Thwaites; Vaira Vike-Freiberga; Chen Wang; Miriam Khamadi Were; Lan Xue; Chandrika Bahadur; Maria Elena Bottazzi; Chris Bullen; George Laryea-Adjei; Yanis Ben Amor; Ozge Karadag; Guillaume Lafortune; Emma Torres; Lauren Barredo; Juliana G E Bartels; Neena Joshi; Margaret Hellard; Uyen Kim Huynh; Shweta Khandelwal; Jeffrey V Lazarus; Susan Michie
Journal:  Lancet       Date:  2022-09-14       Impact factor: 202.731

2.  Investigation of SARS-CoV-2 in hospital indoor air of COVID-19 patients' ward with impinger method.

Authors:  Mehdi Vosoughi; Chiman Karami; Abdollah Dargahi; Farhad Jeddi; Kamyar Mazloum Jalali; Aidin Hadisi; Somayeh Biparva Haghighi; Hadi Peeri Dogahe; Zahra Noorimotlagh; Seyyed Abbas Mirzaee
Journal:  Environ Sci Pollut Res Int       Date:  2021-05-06       Impact factor: 4.223

3.  Distribution of SARS-CoV-2 RNA signal in a home with COVID-19 positive occupants.

Authors:  Juan P Maestre; David Jarma; Jia-Rong F Yu; Jeffrey A Siegel; Sharon D Horner; Kerry A Kinney
Journal:  Sci Total Environ       Date:  2021-03-09       Impact factor: 7.963

4.  Silica-encapsulated DNA tracers for measuring aerosol distribution dynamics in real-world settings.

Authors:  Anne M Luescher; Julian Koch; Wendelin J Stark; Robert N Grass
Journal:  Indoor Air       Date:  2021-10-21       Impact factor: 6.554

Review 5.  Dismantling myths on the airborne transmission of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

Authors:  J W Tang; W P Bahnfleth; P M Bluyssen; G Buonanno; J L Jimenez; J Kurnitski; Y Li; S Miller; C Sekhar; L Morawska; L C Marr; A K Melikov; W W Nazaroff; P V Nielsen; R Tellier; P Wargocki; S J Dancer
Journal:  J Hosp Infect       Date:  2021-01-13       Impact factor: 3.926

6.  Modelling uncertainty in the relative risk of exposure to the SARS-CoV-2 virus by airborne aerosol transmission in well mixed indoor air.

Authors:  Benjamin Jones; Patrick Sharpe; Christopher Iddon; E Abigail Hathway; Catherine J Noakes; Shaun Fitzgerald
Journal:  Build Environ       Date:  2021-01-19       Impact factor: 6.456

7.  Insights into the evaporation characteristics of saliva droplets and aerosols: Levitation experiments and numerical modeling.

Authors:  Christian Lieber; Stefanos Melekidis; Rainer Koch; Hans-Jörg Bauer
Journal:  J Aerosol Sci       Date:  2021-01-22       Impact factor: 3.433

8.  SARS-CoV-2 concentrations and virus-laden aerosol size distributions in outdoor air in north and south of Italy.

Authors:  D Chirizzi; M Conte; M Feltracco; A Dinoi; E Gregoris; E Barbaro; G La Bella; G Ciccarese; G La Salandra; A Gambaro; D Contini
Journal:  Environ Int       Date:  2020-11-12       Impact factor: 13.352

9.  Consumers' Fears Regarding Food Availability and Purchasing Behaviors during the COVID-19 Pandemic: The Importance of Trust and Perceived Stress.

Authors:  Marzena Jeżewska-Zychowicz; Marta Plichta; Maria Królak
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

10.  Modeling the load of SARS-CoV-2 virus in human expelled particles during coughing and speaking.

Authors:  Yang Wang; Guang Xu; Yue-Wern Huang
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.